News | August 13, 2009

Canada's Nuclear Reactor Down Until 2010


August 13, 2009 - The Canadian Prime Minister Stephen Harper expressed disappointment with reports from the Atomic Energy of Canada Ltd. (AECL) that the aging nuclear reactor at Chalk River, Ontario, which produces most of the medical isotopes for Canada and the United States, will not be back up and running until the spring of 2010.

In the meantime, doctors will have to be patient, as technetium-99 supplies are rationed. The reactor produces medical isotopes such as molybdenum-99 (Mo-99), which produce technetium-99 used in diagnostic nuclear imaging scans.

The AECL identified nine sites at the reactor in need of repair. Corrosion experts are advising the AECL, as the group works closely with the Canadian Nuclear Safety Commission, whose safety inspectors are directly involved at the Chalk River site.

The AECL assured the Canadians that the repairs are not a public safety issue, adding there is no threat to workers on site or the environment.

The Canadian ministers of health and natural resources had issued a joint statement Wednesday night saying they're disappointed that the Chalk River facility won't be back online until the first quarter of 2010.

For more information: www.aecl.ca/


Related Content

News | Radiopharmaceuticals and Tracers

April 13, 2023 β€” A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin ...

Home April 13, 2023
Home
News | Radiopharmaceuticals and Tracers

Nov. 4, 2022 β€” On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical ...

Home November 05, 2022
Home
News | Radiopharmaceuticals and Tracers

June 24, 2022 β€” Shortages of pyrophosphate (PYP), the radiopharmaceutical most commonly used in the U.S. for noninvasive ...

Home June 24, 2022
Home
News | Radiopharmaceuticals and Tracers

August 2, 2019 β€” The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...

Home August 02, 2019
Home
News | Radiopharmaceuticals and Tracers

July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot ...

Home July 16, 2019
Home
News | Radiopharmaceuticals and Tracers

June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel ...

Home June 05, 2019
Home
News | Radiopharmaceuticals and Tracers

May 17, 2019 β€” Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular ...

Home May 17, 2019
Home
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor

May 10, 2019 β€” Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in ...

Home May 10, 2019
Home
News | Radiopharmaceuticals and Tracers

October 12, 2018 β€” The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) β€” the voice of the radionuclide ...

Home October 12, 2018
Home
Feature | Radiopharmaceuticals and Tracers | Dave Fornell

February 8, 2018 β€” The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...

Home February 26, 2018
Home
Subscribe Now